Technical Analysis for BIS - ProShares UltraShort Nasdaq Biotechnology
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 17.42 | -1.36% | -0.24 |
BIS closed down 1.36 percent on Wednesday, November 20, 2024, on 1.91 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Sell Signal | Bearish | 0.00% | |
Slingshot Bullish | Bullish Swing Setup | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | -1.36% | |
Above Upper BB | Strength | -1.36% | |
Gapped Up | Strength | -1.36% | |
Overbought Stochastic | Strength | -1.36% |
Alert | Time |
---|---|
Possible NR7 | about 18 hours ago |
Down 1% | about 19 hours ago |
60 Minute Opening Range Breakdown | about 20 hours ago |
5x Volume Pace | about 22 hours ago |
2x Volume Pace | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®.
The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
Classification
Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 23.6938 |
52 Week Low | 13.91 |
Average Volume | 14,128 |
200-Day Moving Average | 16.40 |
50-Day Moving Average | 15.32 |
20-Day Moving Average | 15.75 |
10-Day Moving Average | 16.08 |
Average True Range | 0.45 |
RSI (14) | 68.35 |
ADX | 22.24 |
+DI | 52.55 |
-DI | 22.25 |
Chandelier Exit (Long, 3 ATRs) | 16.66 |
Chandelier Exit (Short, 3 ATRs) | 15.45 |
Upper Bollinger Bands | 17.84 |
Lower Bollinger Band | 13.67 |
Percent B (%b) | 0.9 |
BandWidth | 26.45 |
MACD Line | 0.56 |
MACD Signal Line | 0.26 |
MACD Histogram | 0.2918 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 17.86 | ||||
Resistance 3 (R3) | 17.89 | 17.79 | 17.78 | ||
Resistance 2 (R2) | 17.79 | 17.68 | 17.77 | 17.76 | |
Resistance 1 (R1) | 17.60 | 17.61 | 17.55 | 17.57 | 17.73 |
Pivot Point | 17.50 | 17.50 | 17.47 | 17.48 | 17.50 |
Support 1 (S1) | 17.31 | 17.39 | 17.26 | 17.28 | 17.11 |
Support 2 (S2) | 17.21 | 17.32 | 17.19 | 17.08 | |
Support 3 (S3) | 17.02 | 17.21 | 17.06 | ||
Support 4 (S4) | 16.99 |